DANBURY, Conn., Feb. 16 /PRNewswire/ -- Penwest Pharmaceuticals Co. will conduct a conference call on Thursday, March 2nd at 11:00 a.m. ET to review its financial results for the fourth quarter and year end 2005, which will be released earlier that day.
The conference call will include remarks by Jennifer Good, President and Chief
Operating Officer and Alan Joslyn, Senior Vice President of Research and Development. Domestic Telephone Number: 800-895-1715 International Telephone Number: 785-424-1059 The conference ID is "Penwest."
Please dial in 10 minutes prior to the scheduled start time. The conference call will also be accessible live and as a replay on the Investor Relations section of the Penwest Web site at www.penwest.com.
If you have any questions, please contact Diane D'Alessandro of Penwest at
203-796-3700 or Caroline Gentile of Kekst and Company at 212-521-4800.
Penwest Pharmaceuticals Co.CONTACT: Diane D'Alessandro of Penwest, +1-203-796-3700; or CarolineGentile of Kekst and Company, +1-212-521-4800
